Resuscitation
Volume 80, Issue 5 , Pages 523-528 , May 2009

Slow infusion of calcium channel blockers compared with intravenous adenosine in the emergency treatment of supraventricular tachycardia

  • S.H. Lim

      Affiliations

    • Department of Emergency Medicine, Singapore General Hospital, Outram Road, Singapore 169608, Singapore
    • Corresponding Author InformationCorresponding author. Tel.: +65 6321 4100; fax: +65 6226 0294.
    • ,
  • V. Anantharaman

      Affiliations

    • Department of Emergency Medicine, Singapore General Hospital, Outram Road, Singapore 169608, Singapore
    • ,
  • W.S. Teo

      Affiliations

    • Department of Cardiology, National Heart Centre, Singapore
    • ,
  • Y.H. Chan

      Affiliations

    • Biostatistics Unit, Yong Loo Lin School of Medicine, National University of Singapore, Singapore

Received 29 October 2008 ,Revised 14 January 2009 ,Accepted 19 January 2009.

References 

  1. Schamroth L, Krikler DM, Garrett C. Immediate effects of intravenous verapamil in cardiac arrhythmias. Br Med J. 1972;1:660–662
  2. Singh BN, Nademanee K, Baky SH. Calcium antagonists: clinical use in the treatment of arrhythmias. Drugs. 1983;25:125–153
  3. Standards and guidelines for Cardiopulmonary Resuscitation (CPR) and Emergency Cardiac Care (ECC). JAMA 1986;255:2905–84.
  4. Standards and guidelines for Cardiopulmonary Resuscitation (CPR) and Emergency Cardiac Care (ECC). JAMA 1992;268:2207–40.
  5. Lim SH, Anantharaman V, Teo WS. Slow infusion of calcium channel blockers in the emergency management of supraventricular tachycardia. Resuscitation. 2002;52:167–174
  6. Belhassen B, Glick A, Laniado S. Comparative clinical and electrophysiological effects of adenosine triphosphate and verapamil on paroxysmal reciprocating junctional tachycardia. Circulation. 1988;77:795–805
  7. Hood MA, Smith WM. Adenosine vs verapamil in the treatment of supraventricular tachycardia: a randomised double-crossover trial. Am Heart J. 1992;123:1543–1549
  8. Garratt C, Linker N, Griffith M, Ward D, Camm AJ. Comparison of adenosine and verapamil for termination of paroxysmal junctional tachycardia. Am J Cardiol. 1989;64:1310–1316
  9. Seet CM. Efficacy of intravenous adenosine in treatment of paroxysmal supraventricular tachycardia in the local population. Singapore Med J. 1997;38:525–528
  10. Bellardinelli L, Linden J, Berne RM. The cardiac effects of adenosine. Prog Cardiovas Dis. 1989;32:73–97
  11. Kawai C, Tomotsugu K, Matsuyama E, Okazaki H. Comparative effects of three calcium antagonists, diltiazem, verapamil and nifedipine on the sino-atrial and atrioventricular nodes. Experimental and clinical studies. Circulation. 1981;63:1035–1042
  12. Sung RJ, Elser B, McAllister RG. Intravenous verapamil for termination of re-entrant supraventricular tachycardias. Intracardiac studies correlated with plasma verapamil concentrations. Ann Intern Med. 1980;93:682–689
  13. Sato M, Nagao T, Yamagudi I, Nakajima H, Kiyomoto L. Pharmacological studies on a new 1,5-benzothiazepine derivative (CRD-401). Arzreim Forsch. 1971;21:1338–1343
  14. Jackman WM, Friday KJ, Dias VC. Dose response study of IV diltiazem for termination of supraventricular tachycardia. Circulation. 1989;80(Suppl. II):II-632
  15. Huyke EC, Sung RJ, Dias VC, et al. Intravenous diltiazem for termination of reentrant supraventricular tachycardia: a placebo-controlled, randomized, double-blind, multicenter study. J Am Coll Cardiol. 1989;13:538–544
  16. Madsen CD, Pointer JE, Lynch TG. A comparison of adenosine and verapamil for the treatment of supraventricular tachycardia in the pre-hospital setting. Ann Emerg Med. 1995;25:649–655
  17. Brady WJ, DeBehnke DJ, Wickmann LL, Lindbeck G. Treatment of out-of-hospital supraventricular tachycardia: adenosine versus verapamil. Acad Emerg Med. 1996;3:574–585
  18. DiMarco JP, Miles W, Akhtar M, Milstein S, Sharma AD, et al. Adenosine for PSVT; Dose ranging and comparison with Verapamil. Ann Intern Med. 1990;113:104–110
  19. Cairns CB, Niemann JT. Intravenous adenosine in the emergency department management of paroxysmal supraventricular tachycardia. Ann Emerg Med. 1991;20:717–721
  20. Klein HO, Ninio R, Orem V, et al. The acute hemodynamic effects of IV verapamil in coronary artery disease. Assessment by equilibrium-gated radionuclide ventriculography. Circulation. 1983;67:101–110
  21. Miyagawa K, Dohi Y, Ogihira M, Sato K. Administration of intravenous calcium before verapamil to prevent hypotension in elderly patients with paroxysmal supraventricular tachycardia. J Cardiovas Pharm. 1993;22:273–279
  22. Holdgate A, Foo A. Adenosine versus intravenous calcium channel antagonists for the treatment of supraventricular tachycardia in adults. Cochrane Database Syst Rev. 2006;1:CD 005154

☆ A Spanish translated version of the summary of this article appears as Appendix in the final online version at doi:10.1016/j.resuscitation.2009.01.017.

PII: S0300-9572(09)00057-4

doi: 10.1016/j.resuscitation.2009.01.017

Resuscitation
Volume 80, Issue 5 , Pages 523-528 , May 2009

Article Tools

* Image Usage & Resolution